The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studies.
Landeiro F. et al, (2024), Lancet Healthy Longev
Decision-Making for Preventive Interventions in Asymptomatic Patients.
Raabe A. et al, (2024), Stroke, 55, 1951 - 1955
How to assess whether a complex intervention for chronic conditions is cost-effective?
Luengo-Fernandez R., (2024), Lancet Reg Health Eur, 42
Health-related quality of life and healthcare costs of symptoms and cardiovascular disease events in patients with atrial fibrillation: a longitudinal analysis of 27 countries from the EURObservational Research Programme on Atrial Fibrillation general long-term registry.
Walli-Attaei M. et al, (2024), Europace, 26
Perinatal Science International: A new meeting of the European Association of Perinatal Medicine
Modi N. et al, (2024), European Journal of Obstetrics and Gynecology and Reproductive Biology, 297, 159 - 160
How to assess whether a complex intervention provides value for money.
LUENGO-FERNANDEZ R., (2024), The Lancet Regional Health - Europe
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries.
Luengo-Fernandez R. et al, (2024), Eur Heart J Qual Care Clin Outcomes, 10, 36 - 44
Infection, delirium, and risk of dementia in patients with and without white matter disease on prior brain imaging: population-based study
PENDLEBURY S. et al, (2023), The Lancet. Healthy Longevity
Economic burden of cardiovascular diseases in the European Union: a population-based cost study.
Luengo-Fernandez R. et al, (2023), Eur Heart J, 44, 4752 - 4767
NHS reference costs: a history and cautionary note.
Amies-Cull B. et al, (2023), Health Econ Rev, 13
Association of multimorbidity with mortality after stroke stratified by age, severity, aetiology, and prior disability.
Downer MB. et al, (2023), Int J Stroke
Improving sleep after stroke: A randomised controlled trial of digital cognitive behavioural therapy for insomnia.
Fleming MK. et al, (2023), J Sleep Res
Association of prior multimorbidity with aetiological subtype and severity of ischaemic stroke: a population-based study
Downer M. et al, (2023), INTERNATIONAL JOURNAL OF STROKE, 18, 24 - 24
Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries
Walli-Attaei M. et al, (2023), EUROPEAN HEART JOURNAL, 44
Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Luengo-Fernandez R. et al, (2022), Thorax
Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study.
Candio P. et al, (2022), Health Policy
The impact of prior multimorbidity on the long-term risk and costs of institutionalisation after stroke: a population-based study (P1-1.Virtual)
Downer M. et al, (2022), NEUROLOGY, 98
Long-Term Impact of Urgent Secondary Prevention After Transient Ischemic Attack and Minor Stroke: Ten-Year Follow-Up of the EXPRESS Study.
Luengo-Fernandez R. et al, (2021), Stroke
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial.
Psallidas I. et al, (2021), Lancet Respir Med